BlackRock Institutional Trust’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$45.3M Buy
1,730,076
+69,607
+4% +$1.72M 0.01% 1409
2016
Q3
$41.5M Buy
1,660,469
+157,459
+10% +$3.67M 0.01% 1406
2016
Q2
$32.6M Sell
1,503,010
-65,064
-4% -$1.16M 0.01% 1521
2016
Q1
$23.5M Sell
1,568,074
-5,017
-0.3% -$84.1K ﹤0.01% 1707
2015
Q4
$34.5M Sell
1,573,091
-13,112
-0.8% -$244K 0.01% 1488
2015
Q3
$25M Sell
1,586,203
-97,799
-6% -$1.57M ﹤0.01% 1674
2015
Q2
$24.1M Sell
1,684,002
-11,208
-0.7% -$190K ﹤0.01% 1797
2015
Q1
$29.3M Buy
1,695,210
+49,183
+3% +$869K ﹤0.01% 1684
2014
Q4
$29.5M Buy
1,646,027
+10,659
+0.7% +$172K ﹤0.01% 1659
2014
Q3
$21.5M Sell
1,635,368
-78,036
-5% -$1.05M ﹤0.01% 1824
2014
Q2
$24.6M Buy
1,713,404
+1,585
+0.1% +$20.7K ﹤0.01% 1817
2014
Q1
$21.8M Sell
1,711,819
-243,239
-12% -$3.17M ﹤0.01% 1895
2013
Q4
$19.6M Sell
1,955,058
-220,442
-10% -$2.5M ﹤0.01% 1958
2013
Q3
$28.6M Buy
2,175,500
+600,359
+38% +$7.88M 0.01% 1591
2013
Q2
$22.5M Buy
+1,575,141
New +$19.8M ﹤0.01% 1720

Other funds holding NXTM

BlackRock Institutional Trust's NXTM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its NxStage Medical Inc. (NXTM) stake by 4.2% in Q4 2016, buying an estimated $1.72M and bringing the position to 1,730,076 shares worth $45.3M. The position accounts for 0.01% of the portfolio, ranked #1409.

BlackRock Institutional Trust first reported a position in NXTM in Q2 2013 and has held it in 15 quarters since. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • BlackRock Institutional Trust held 1,730,076 shares of NxStage Medical Inc. worth $45.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 69,607 NxStage Medical Inc. shares in Q4 2016, an estimated $1.72M.
  • NxStage Medical Inc. made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1409 holding.
  • BlackRock Institutional Trust first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 15 quarters since.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.